Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $146.2800 (-0.76%) ($146.0150 - $147.6800) on Fri. Jan. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.09% (three month average) | RSI | 9 | Latest Price | $146.2800(-0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(22%) XLV(20%) XOP(19%) SPLV(17%) XLE(17%) | Factors Impacting ABBV price | ABBV will decline at least -0.545% in a week (0% probabilities). XLC(-14%) IPO(-11%) VXX(-8%) BWX(-8%) ONLN(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.545% (StdDev 1.09%) | Hourly BBV | -0.3 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $154.73 | 5 Day Moving Average | $147.54(-0.85%) | 10 Day Moving Average | $149.04(-1.85%) | 20 Day Moving Average | $154.73(-5.46%) | To recent high | -12.2% | To recent low | 1.3% | Market Cap | $258.079b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |